• Ultralife posted a net loss of USD 0.5 million, or USD 0.03 per share, swinging from profit a year earlier as revenue fell 6.5% to USD 47.4 million.
• Gross profit slid to USD 10.1 million, cutting gross margin to 21.3% from 25.1% a year earlier.
• Adjusted EBITDA declined to USD 3.2 million from USD 5.4 million a year earlier.
• Backlog climbed to a record USD 115.1 million from USD 110.2 million at end-2025.
• CEO Mike Manna cited lost production days at Newark, NY due to a power outage, additional downtime at Raynham, MA tied to inventory-related integration work and weather, while Communications Systems sales stayed weak on continued order delays.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultralife Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605080700PRIMZONEFULLFEED9716053) on May 08, 2026, and is solely responsible for the information contained therein.